Emerging Psychedelic Therapies for Depression Charles DeBattista, MD (videos)

https://reference.medscape.com/viewarticle/major-depressive-disorder-emerging-psychedelic-therapies-2026a1000wku Many patients with depression do not find symptom relief from the current range of approved treatments. Psychedelic therapies are emerging as an option to address this unmet need, as outlined by Dr Charles DeBattista of Stanford University. Dr DeBattista explains that psilocybin and LSD were studied in depression in the 1950s and 1960s. Recent interest has led to more rigorous examination of their benefits and the potential for approval in 2027. https://www.medscape.com/video?_gl=1*1cehy2z*_gcl_aw*R0NMLjE3OTQxNTA2NTEuQ2p3S0NBaUEyTURYQmhCVUVpd0FELVlCLXd1b01GR3dXT21oQVlPX1loTFBUYVNTZHBWUDRLUjFwZkt5NGhBdEhVbURyUUdrcFR0NUh4b0NFaWNRQXZEX0J3RQ..*_gcl_au*MTA2Mzc5MDEwMS4xNzg5ODMwNjQxLjE3NTgwOTUyMDguMTc5NDIzODgwMC4xNzk0MjM4Nzk5Ljc0MjUxOTQ1MC4xNzk0MjMxMTY2LjE3OTQyMzg3OTk.